HomePi-Cardia Ltd

Pi-Cardia Ltd

ShortCut Device Used to Treat a Patient Reported a Success

ShortCut is the world’s first dedicated device designed to split the leaflets of a pre-existing valve to enable safe Transcatheter Aortic Valve Replacement in patients at risk for coronary obstruction or compromised coronary access.

Non-Implant Based Leaflex™ Catheter First-in-Human Study Results

The First-In-Human study aimed to demonstrate safety, feasibility and acute performance of the Leaflex™ catheter as a standalone treatment, and included sixteen (16) transfemoral cases where Leaflex™ was used prior to TAVR.